Med. praxi. 2017;14(2):77-80 | DOI: 10.36290/med.2017.015

Diagnosis and treatment of Lyme Disease

MUDr. Dita Smíšková, Ph.D.1, 2, doc. MUDr. Dušan Pícha, CSc.1
1Klinika infekčních nemocí 2. LF UK a Nemocnice Na Bulovce, Praha, 2Klinika infekčních, parazitárních a tropických nemocí, Nemocnice Na Bulovce, Praha

Lyme borreliosis is a bacterial infection transmitted by ticks that affects various organs and tissues. Diagnostic difficulty is caused

mainly by diversity of clinical manifestations and low availability and applicability of direct laboratory methods. Identification of

specific IgM and IgG antibodies is still the basis of laboratory diagnostics nowadays. However, serological tests merely confirm

contact with the disease, but do not correlate with activity of the infection. To make the right diagnosis, thorough evaluation of

the clinical manifestation as well as laboratory results is necessary. Tetracyclines, penicillins, cephalosporins and macrolides are

the main groups of antibiotics effective against Lyme disease. Unsatisfactory clinical response to antibiotic treatment should lead

to reevaluation of the diagnosis and consideration of other, non-infectious causes of the symptoms. Repeating or prolonging of

the antibiotic treatment is not recommended.

Keywords: lyme disease, erythema migrans, Bannwarth syndrome, neuroborreliosis, diagnostics, treatment

Published: May 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Smíšková D, Pícha D. Diagnosis and treatment of Lyme Disease. Med. praxi. 2017;14(2):77-80. doi: 10.36290/med.2017.015.
Download citation

References

  1. Stanek G, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011; 17(1): 69-79. Go to original source... Go to PubMed...
  2. Prasad A, Sankar D. Overdiagnosis and overtreatment of Lyme neuroborreliosis are preventable. Postgrad Med J 1999; 75(889): 650-656. Go to original source... Go to PubMed...
  3. Dlouhý P, Krbková L, Pícha D, et al. Lymeská borrelióza: Doporučený postup v diagnostice, léčbě a prevenci 2011. Dostupný z: http://www.infekce.cz/DoporLB11.htm
  4. Picha D, Moravcová L, Vanousová D, et al. DNA persistence after treatment of Lyme borreliosis. Folia Microbiol (Praha) 2014; 59(2): 115-125. Go to original source... Go to PubMed...
  5. Ornstein K, et al. Three major Lyme Borrelia genospecies (Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii) identified by PCR in cerebrospinal fluid from patients with neuroborreliosis in Sweden. Scand J Infect Dis 2002; 34(5): 341-346. Go to original source... Go to PubMed...
  6. Cerar T, Ogrinc K, Cimperman J, et al. Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis. J Clin Microbiol 2008; 46(10): 3375-3379. Go to original source... Go to PubMed...
  7. Moore A, et al. Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States. Emerg Infect Dis 2016: 22(7). Go to original source... Go to PubMed...
  8. Tuuminen T, et al. Acute Parvovirus B19 Infection Causes Nonspecificity Frequently in Borrelia and Less Often in Salmonella and Campylobacter Serology, Posing a Problem in Diagnosis of Infectious Arthropathy. Clinical and Vaccine Immunology: CVI, 2011; 18(1): 167-172. Go to original source... Go to PubMed...
  9. Picha D, Moravcova L, Smiskova D. Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections. J Neurol Sci 2016; 368: 214-220. Go to original source... Go to PubMed...
  10. Sanchez E, Vannier E, Wormser GP, et al. Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review. JAMA, 2016; 315(16): 1767-1777. Go to original source... Go to PubMed...
  11. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med, 2001; 345(2): 85-92. Go to original source... Go to PubMed...
  12. Krupp LB, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology, 2003; 60(12): 1923-1930. Go to original source... Go to PubMed...
  13. Kaplan RF, et al. Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology, 2003; 60(12): 1916-1922. Go to original source... Go to PubMed...
  14. Roháčová H. Lymeská borrelióza. Interní medicína pro praxi 2012; 14(5): 203-205.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.